ArticleJournal of dental sciences2023
The dental use for periodontal diseases under the national health insurance system in Taiwan in 2021.
Article in Journal of dental sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Oral health-related quality of life and diabetes outcomes: Evidence from a nationally representative U.S. sample.Journal of dental sciences · 2026Article
- Evaluation of the performance of an artificial intelligence model in recognizing the habitual mixed language in Taiwan for generating periodontal charting text reports.Journal of dental sciences · 2026Article
- Integrated Strategies for Early Diagnosis and Prevention of Oral Diseases in Asia Pacific.International journal of environmental research and public health · 2025Article
- Trends of dental service utilization and expenditure in Taiwan from 2000 to 2020.Journal of dental sciences · 2024Article
- In vitro cytotoxicity and antibacterial activity of hypochlorous acid antimicrobial agent.Journal of dental sciences · 2024Article
- Gender differences in oral health among prisoners: a cross-sectional study from Taiwan.BMC oral health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Periodontal disease is one of the main oral diseases in humans. This study investigated the dental use for periodontal diseases under the National Health Insurance system (NHI) system in Taiwan in 2021. Materials and methods: The population data and medical records of the NHI system were obtained from the websites of the Ministry of the Interior and the NHI Administration, respectively. The dental patient data were divided into 18 age groups to analyze the dental use indicators for periodontal diseases under the NHI system in Taiwan in 2021. Results: The dental use rate for treatment of periodontal diseases (including gingivitis and periodontitis) had the highest peak (51.85%) in the 5-9-year age group under the NHI system in Taiwan in 2021. It dropped abruptly to a lower point (38.20%) in the 15-19-year age group, fluctuated and declined gradually with increasing age, and finally dropped to the lowest point of 18.78% in the greater than 85-year age group. Furthermore, the number of out-patient visits per 1000 people showed a similar trend. However, the medical expenses per person also showed a similar trend except the findings of the highest peak in the 55-59-year age groups. Conclusion: Periodontal disease is still the main disease of the oral cavity in Taiwan. From a cost-effectiveness viewpoint, Taiwan government shall develop a better oral health policy to decrease the incidence of periodontal diseases and to prevent periodontal diseases from deteriorating into the end age of tooth loss for all citizens, especially for patients of special needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.